User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

  • Open access
  • PDF
  • 1.22 M
Bibliographic reference Moreau, Philippe ; Attal, Michel ; Hulin, Cyrille ; Arnulf, Bertrand ; Belhadj, Karim ; et. al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.. In: Lancet, Vol. 394, no. 10192, p. 29-38 (2019)
Permanent URL http://hdl.handle.net/2078.1/216852